CTNNB1 and neoplasm: CTNNB1 mutation enriched in high-infiltration group was associated with stronger recruitment of activated/effector memory CD8 T subsets and less enrichment in monocytes, macrophages, type 2 helper cells and type 17 helper cells, thus suggesting that CTNNB1 mutation enhances anti-tumor immunity and facilitates immunotherapy.